Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Equivalent or similar to OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity in Rodents), with deviations (no data on haematology, clinical biochemistry and organ weight measurements)

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1980

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
Deviations:
yes
Remarks:
(No data on haematology, clinical biochemistry and organ weight measurements)
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate
Cas Number:
7177-48-2
Molecular formula:
C16H25N3O7S
IUPAC Name:
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate
Details on test material:
- Name of test material (as cited in study report): Ampicillin trihydrate
- Lot/batch No.: 61849K
- Other:
Supplier: E.R. Squibb & Sons, Inc. (Princeton, NJ), manufactured by Ersana, Inc. (Humacao, Puerto Rico)

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles Rive:r Breeding Laboratories (Portage, MI)
- Age at study initiation: 7 weeks of age
- Housing: All animals were housed five per cage; Polycarbonate (Lab Products, Int ., Rochelle Park, NJ)
- Diet (e.g. ad libitum): NIH 07 Rat and Mouse Ration (Zeigler Bros , Gardners, PA]; available ad libitum
- Water (e.g. ad libitum): Half deionized/half tap water; automatic watering system (Edstrom Industries, Waterford, VII); available ad libitum.
- Acclimation period: 15 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.44 ± 0.84 ºC
- Humidity (%): 53 ± 7.4%
- Air changes (per hr): 12 room air changes/h
- Photoperiod (hrs dark / hrs light): fluorescent light 12 h/d

IN-LIFE DATES: From 20/12/1979 to 19/3/1980

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on oral exposure:
- Justification for use and choice of vehicle (if other than water): Ampicillin trihydrate is only slightly soluble in water; therefore, corn oil was selected to improve suspendability in the gavage vehicle.
- Preparation: Weighed ampicillin trihydrate was mixed with corn oil in Waring blender, transferred to volumetric flask and brought to volume with corn oil, mixed in flask, then transferred to a beaker and mixed with a stirring bar and magna-stirrer.
- Amount of vehicle (if gavage): 5 mL/kg bw
Analytical verification of doses or concentrations:
no
Duration of treatment / exposure:
13 weeks
Frequency of treatment:
5 days/week
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 180, 370, 750, 1500 or 3000 mg/kg ampicillin trihydrate in corn oil by gavage; 3000 mg/kg group given 1500 mg/kg 2 X d at least 5 h apart.
Basis:
actual ingested
No. of animals per sex per dose:
10
Control animals:
yes, concurrent vehicle
Details on study design:
- Dose selection rationale:
The highest dose of 3000 mg/kg was selected because no dose-related deaths were seen at 2400 mg/kg in a 14-day study. This dose is the maximum one that was practical to administer to rats (administered as two 1500 mg/kg doses with a dose volume of 5 mL/kg body weight).

Examinations

Observations and examinations performed and frequency:
Observation: 2/day
Body weight: 1/week
Sacrifice and pathology:
Necropsy performed on all animals.

Histologic exams performed on vehicle control and 3000 mg/kg group and on all animals dying during the study.

Tissues examined: regional lymph nodes, skin, mandibular lymph nodes, mammary gland, salivary glands, thigh muscle, sciatic nerve, bone marrow, costo-chondral junction (rib), thymus, larynx, trachea, lungs and bronchi, heart, thyroid gland, parathyroids, esophagus, stomach, duodenum, jejunum, ileum, colon, rectum, mesenteric lymph nodes, liver, pancreas, spleen, kidneys, adrenal glands, urinary bladder, seminal vesicles/prostate/testis or ovaries/uterus, nasal cavity, brain, pituitary gland, eyes, external and middle ear, and spinal cord.

Results and discussion

Results of examinations

Details on results:
CLINICAL SIGNS AND MORTALITY
The 12 deaths observed in dosed and vehicle control rats were considered to be due to gavage error.
Male and female rats that received 3000 mg/kg ampicillin trihydrate had diarrhea.

BODY WEIGHT AND WEIGHT GAIN
The final mean body weights of the female rats were not related to the dose levels. The final mean body weight of the males that received 3000 mg/kg was 9% lower than that of the vehicle controls.

GROSS PATHOLOGY
No compound-related gross pathology effects were observed.

HISTOPATHOLOGY
No compound-related histopathologic effects were observed.

No dose-related effects were seen in the 13-week studies at 1500 or 3000 mg/kg.

Effect levels

Dose descriptor:
NOEL
Effect level:
3 000 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: see 'Remark'

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
No dose-related effects were seen in the 13-week study at 1500 or 3000 mg/kg.
Executive summary:

A thirteen-week study was conducted to evaluate the cumulative toxic effects of repeated administration of ampicillin trihydrate.

Groups of 10 rats of each sex were administered 0,180, 370, 750, 1500, or 3000 mg ampicillin trihydrate/kg in corn oil by gavage, 5 days per week for 13 weeks (dose volume: 5 mL/kg body weight)

Necropsy was performed on all animals. Histologic exams were performed on vehicle control and 3000 mg/kg group and on all animals dying during the study. Tissues examined were: regional lymph nodes, skin, mandibular lymph nodes, mammary gland, salivary glands, thigh muscle, sciatic nerve, bone marrow, costo-chondral junction (rib), thymus, larynx, trachea, lungs and bronchi, heart, thyroid gland, parathyroids, esophagus, stomach, duodenum, jejunum, ileum, colon, rectum, mesenteric lymph nodes, liver, pancreas, spleen, kidneys, adrenal glands, urinary bladder, seminal vesicles/prostate/testis or ovaries/uterus, nasal cavity, brain, pituitary gland, eyes, external and middle ear, and spinal cord.

The final mean body weights of the female rats were not related to the dose levels. The final mean body weight of the males that received 3000 mg/kg was 9% lower than that of the vehicle controls. Male and female rats that received 3000 mg/kg ampicillin trihydrate had diarrhea. No compound-related gross or histopathologic effects were observed.

No dose-related effects were seen in the 13-week study at 1500 or 3000 mg/kg.